86exporter.com Home       Products Catalog      Suppliers Catalog      Log In        Sign up
      About Us
      Profile
      Products
      Contact Us

 


Shenzhen Nexconn Pharmatechs Ltd

All Products >> active pharmaceutical ingredient

Showing 1 - 2 of 2, total 1 pages        [First] [Previous] [Next] [Last]

1
dabigatran etexilate mesylate
dabigatran etexilate mesylate
Specification: 99%+ purity, unknown single impurity<0.1%
Detail: Dabigatran etexilate mesylate was first approved by EMA on May 18,2008, then approved by the USA FDA on Oct 19,2010, and approved by P*** on Jan 21,2011. It was developed and marketed as Pradaxa by Boehringer Ingelheim in DE a...

2
rivaroxaban
rivaroxaban
Specification: 99%+ purity, unknown single impurity<0.1%
Detail: Rivaroxaban was first approved by Health Canada on September 15, 2008, then approved by European Medicine Agency£¨EMA£©on September 30, 2008, and approved by the US Food and Drug Administration£¨FDA£© on July 01,2011. It was d...
Showing 1 - 2 of 2, total 1 pages        [First] [Previous] [Next] [Last]
1 


Copyright© Shenzhen Nexconn Pharmatechs Ltd All Rights Reserved.
Tel : +86-755-89396905 Fax : +86-755-22712255
Powered by 86exporter.com